IN THE NEWS: ADVANCES IN NANOTECHNOLOGY

In addition to the discussed perks of a nano-encapsulated ingestible supplement or liquid based vitamin, nanotechnology is also making waves in another department of medicine. It appears that the University of Leicester's Dr Wu Su was awarded a rare Postdoctoral Research Fellowship grant worth 321 K. This undeniable financial boost is allowing a multi-disciplinary team of scientists (Chemistry to Physics to Molecular Medicine) the chance to revolutionize cancer diagnosis and treatment.

That's primarily prostate cancer…at least for the moment. The idea, that magnetic nano-particles (5-100 nm in size) could be efficiently affect unique cell surface receptors on the prostate, is not unlike the nutrient delivery system designed for nano-encapsulated ingestibles. But, applying it to the juggernaut cancer industry is a definite feather in the proverbial cap of this intriguing technology.

According to the University of Leicester's own Dr. Glenn Burley, "High-performance magnetic nano-particles act as probes that show up (using Magnetic Resonance Imaging) and kill (by hypothermia) tumor cells at a much earlier stage than conventional methods."

According to Dr. Su himself, "Prostate cancer cure rates are predicated on early diagnosis and treatment. The technology that we are developing offers the potential of both the identification and treatment of prostate cancer in a highly selective manner."

Not only that. These particular magnetic nano-particles, galvanized by Su's team all-star team, are supposedly increased by a factor of ten. If it works as it should, this pioneering technology will surely be brought to other forms of cancer and to the sounds of celebration from a consistently increasing list of families…at least in the U.K.

The cost benefits of implementing such a system are unquestionable. Like nano-encapsulated vitamins, there is an opportunity to increase overall bio-availability here. Unleashing magnetic nano-particles on cancer cells would, in many cases, quash the need to perform surgery or remove the prostate. Although pharmaceutical companies may suffer in the end, this system of cancer treatment would allow for the conservation of countless medical material and labor, not to mention significant welfare benefits for patients. Its inevitable struggle for credibility will be interesting to observe.

© Wellness Information Services

|    Privacy Policy    |     Site Map    |     Contact Us    |     Copyright © 2012 The Source Vitamin Company, Inc.    |    livethesource® is a registered trademark of The Source Vitamin Company, Inc.    |